Sangdun C. Choi
Ajou University Campus Plaza 418, Worldcup Ro 199, Yeongtong Gu, Suwon 16502
Suwon, Republic of Korea
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Predictive neural networks accelerate identification of mechanistically validated small-molecule modulators of TLR7 signaling.
Journal: Biochemical pharmacology
Published: April 05, 2026
Generative AI Uncovers Novel Chrebp/Txnip Axis Inhibitors with Potential Anti-inflammatory Activity.
Generative AI Uncovers Novel Chrebp/Txnip Axis Inhibitors with Potential Anti-inflammatory Activity.
Journal: Journal of chemical information and modeling
Published: February 26, 2026
NIM5 series brain-penetrant NLRP3 inflammasome inhibitors suppress neuroinflammation in EAE and Alzheimer's models.
Journal: International journal of biological macromolecules
Published: January 30, 2026
Structural and molecular characterization of a small-molecule TNF-α-TNFR1 inhibitor modulating cell death signaling.
Journal: Biochemical pharmacology
Published: November 14, 2025
AI-assisted design of a VEGFR2 agonistic peptide that promotes angiogenesis and wound repair.
Journal: Protein science : a publication of the Protein Society
Published: November 02, 2025
Corrigendum to "A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models" [eBioMedicine 52 (2020) 102645].
Journal: EBioMedicine
Published: October 30, 2025
Deep learning-guided discovery of IL23/IL23R macromolecular inhibitors: An integrative framework combining virtual screening and experimental validation.
Journal: International journal of biological macromolecules
Published: October 25, 2025
AI-guided integrative discovery of PD-1/PD-L1 interface inhibitors through multiscale modeling and experimental validation.
Journal: International journal of biological macromolecules
Published: October 14, 2025
Molecular and functional characterization of a novel Toll-like receptor 9-specific DNA aptamer with therapeutic potential.
Journal: International immunopharmacology
Published: October 02, 2025
Discovery of a novel selective small molecule interleukin-36 receptor antagonist for inflammation and cancer.
Journal: Biochemical pharmacology
Published: September 06, 2025
Discovery of selective TLR9 antagonists via machine learning-driven structural modeling and experimental validation.
Journal: International journal of biological macromolecules
Published: August 27, 2025
Last Updated: 09/26/2026